Skip to content

Clinical Study on Early Onset Ovarian Insufficiency Treated by Circular Motion Acupuncture Therapy Based on the Theory of One Origin with Three Branches

Clinical Study on Early Onset Ovarian Insufficiency Treated by Circular Motion Acupuncture Therapy Based on the Theory of One Origin with Three Branches

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001639
Enrollment
Unknown
Registered
2026-06-30
Start date
2026-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian insufficiency

Interventions

Circular Motion Acupuncture and Moxibustion Therapy:Acupuncture and Moxibustion combined with Femoston, ovulation induction therapy and fertility guidance
Circular Motion Acupuncture Therapy:Acupuncture combined with Femoston, ovulation induction therapy and fertility guidance

Sponsors

Hubei University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Female patients aged 20-40 years with premature ovarian insufficiency (Premature Ovarian Insufficiency) who have fertility needs. (2) Patients who have not received other Premature Ovarian Insufficiency treatments recently (excluding ovulation induction and egg retrieval for assisted reproduction). (3) Patients who voluntarily agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Complicated by other serious internal or surgical diseases, such as cardiovascular diseases, hepatic or renal insufficiency, malignant tumors, etc. (2) Infertile patients due to spousal reproductive disorders. (3) Patients with organic lesions in the uterine and adnexal regions. (4) Patients with psychiatric disorders who are unable to cooperate with treatment and follow-up. (5) Patients who have recently participated in other clinical trials. (6) Patients who are intolerant or allergic to acupuncture and moxibustion.

Design outcomes

Primary

MeasureTime frame
Uterine Hemodynamics;Rate of cycles with dominant follicles;

Secondary

MeasureTime frame
Follicle-stimulating hormone;Estradiol;Anti-Müllerian hormone;luteinizing hormone;TCM syndrome score;Pregnancy rate;

Countries

China

Contacts

Public ContactXV danning

Hubei University of Chinese Medicine

1913878224@qq.com13437150941

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026